Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Cytarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 488 Leukemia 246 Precursor Cell Lymphoblastic Leukemia-Lymphoma 198 Lymphoma 133 Myelodysplastic Syndromes 95 Burkitt Lymphoma 77 Lymphoma, Non-Hodgkin 74 Leukemia, Monocytic, Acute 74 Congenital Abnormalities 73 Leukemia, Myelomonocytic, Acute 71 Leukemia, Erythroblastic, Acute 66 Lymphoma, Large B-Cell, Diffuse 65 Leukemia, Megakaryoblastic, Acute 63 Recurrence 59 Lymphoma, Mantle-Cell 58 Lymphoma, Follicular 42 Hodgkin Disease 40 Leukemia, Myelomonocytic, Chronic 39 Leukemia, Biphenotypic, Acute 37 Lymphoma, Large-Cell, Immunoblastic 34 Anemia, Refractory, with Excess of Blasts 30 Myeloproliferative Disorders 29 Leukemia, Lymphocytic, Chronic, B-Cell 29 Blast Crisis 29 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 27 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 24 Lymphoma, B-Cell, Marginal Zone 21 Leukemia, Myeloid, Chronic-Phase 21 Multiple Myeloma 20 Leukemia, Eosinophilic, Acute 19

Interventions

Trastuzumab 520 Paclitaxel 472 Cyclophosphamide 467 Docetaxel 411 Capecitabine 348 Letrozole 309 Fulvestrant 268 Doxorubicin 245 Tamoxifen 228 Carboplatin 224 Anastrozole 197 Radiotherapy 193 exemestane 186 Epirubicin 170 Bevacizumab 166 palbociclib 149 Lapatinib 145 Vinorelbine 143 pertuzumab 141 Gemcitabine 138 pembrolizumab 136 Surveys and Questionnaires 118 Exercise 110 Magnetic Resonance Spectroscopy 109 eribulin 103 Fluorouracil 101 Albumin-Bound Paclitaxel 100 Blood Specimen Collection 96 130-nm albumin-bound paclitaxel 90 Everolimus 87

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01645839 2019-06-12

DEPOSEIN

Centre Oscar Lambret

Phase 3 Completed

Breast Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡